GlassScriptPhysician profile
Amar Kirti Kalidas
NPI 1104186923
$2,079.09
in general payments reported to CMS, 2019-2025
5 companies · $2,079 in 2025
The $2,079 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $2,079.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $2,000 · Food and Beverage: $79.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $2,000.00 |
| Food and Beverage | $79.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $2,000.00 | 2025 | Neurostar Tms Therapy System |
| Abbott Laboratories | $23.13 | 2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $22.95 | 2025 | The Cologuard Plus Collection Kit |
| Amneal Pharmaceuticals LLC | $18.48 | 2025 | Unithroid |
| Acella Pharmaceuticals, LLC | $14.53 | 2025 | NP Thyroid 60 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Kalidas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.